| GTO ID | GTC1005 |
| Trial ID | ChiCTR2200061555 |
| Disease | Lung Cancer |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical study on the safety and efficacy of CAR-T cells in the treatment of advanced lung cancer |
| Year | 2022 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Dalian Medical University |
| Cohort 1 | |||||||
|
|||||||